Owners, management and financials
CVR: 40738223
Secondary names: TPT ApS
DKK -17,669,007
Gross profit
Net result: DKK -52,589,605
RUMP INVEST ApS (5-9,99%), Breum Holding EST. 2016 ApS (20-24,99%)
4 more
CVR · view owners
Rolf Sass Sørensen, Ulrich Wulff Norden Venge
Board: Søren Maarssø (chair) and 3 members
CVR · view management
Active
Founded 26 August 2019
CVR · view overview
39 employees
CVR · 2026
Director role ended: Jesper Breum
CVR · 06/10/2026
View the full event history
Tetra Pharm Technologies ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Rolf Sass Sørensen and Ulrich Wulff Norden Venge. The board consists of Søren Maarssø (chair), Claus Berner Nielsen, Jesper Breum and Rolf Sass Sørensen. The company's owners include RUMP INVEST ApS, Breum Holding EST. 2016 ApS and BrainFrame ApS. The company has 39 employees (2026). In 2025, the company reported a gross profit of DKK -17,669,007 and a net result of DKK -52,589,605 compared with DKK -55,213,708 the year before. Equity in the 2025 report amounted to DKK -25,844,292.
Selskabets formål er at være biotekselskab, investering samt enhver beslægtet virksomhed efter ledelsens beslutning.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -17.7M | -52.6M | 22.6M | -25.8M | 47 | |
| 202401/01/2024 – 31/12/2024 | 1.5M | -55.2M | 31.3M | 26.7M | 37 | |
| 202301/01/2023 – 31/12/2023 | 585K | -32.9M | 34.6M | 32.1M | 24 | |
| 202201/01/2022 – 31/12/2022 | -510K | -7.8M | 85.3M | 79.9M | 15 | |
| 202101/01/2021 – 31/12/2021 | 3.2M | 306K | 14.4M | 9.9M | 6 |
Compared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Tetra Pharm Technologies ApS is 40738223.
The owners of Tetra Pharm Technologies ApS include RUMP INVEST ApS, Breum Holding EST. 2016 ApS and BrainFrame ApS.
The management of Tetra Pharm Technologies ApS consists of Rolf Sass Sørensen and Ulrich Wulff Norden Venge.
The board of Tetra Pharm Technologies ApS consists of Søren Maarssø, Claus Berner Nielsen and Jesper Breum, with Søren Maarssø as chair.
In 2025, Tetra Pharm Technologies ApS reported a gross profit of DKK -17,669,007.
Tetra Pharm Technologies ApS had 39 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 31194556, new email: [email protected], new website: https://www.tetrapharm.eu/ (October 12, 2026).
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (October 8, 2026).
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (October 7, 2026).
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (October 6, 2026).
As of October 6, 2026, Ulrich Wulff Norden Venge is registered as director of Tetra Pharm Technologies ApS.
As of October 6, 2026, Rolf Sass Sørensen is registered as director of Tetra Pharm Technologies ApS.
As of October 6, 2026, Jesper Breum has stepped down as director of Tetra Pharm Technologies ApS.
As of October 6, 2026, Martin Stefan Rose has stepped down as director of Tetra Pharm Technologies ApS.
Tetra Pharm Technologies ApS has published its annual report for 2025. Gross profit came to DKK -17,669,007, and the net result was DKK -52,589,605.
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (July 8, 2026).
As of July 1, 2026, Rolf Sass Sørensen has joined the board of directors of Tetra Pharm Technologies ApS.
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (June 4, 2026).
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (May 28, 2026).
As of May 1, 2026, Claus Berner Nielsen has joined the board of directors of Tetra Pharm Technologies ApS.
As of May 1, 2026, Jesper Breum has joined the board of directors of Tetra Pharm Technologies ApS.
As of May 1, 2026, Søren Maarssø has joined the board of directors of Tetra Pharm Technologies ApS.
As of May 1, 2026, Martin Stefan Rose has left the board of directors of Tetra Pharm Technologies ApS.
As of May 1, 2026, Lars Frøvang Thomsen has left the board of directors of Tetra Pharm Technologies ApS.
As of May 1, 2026, RUMP INVEST ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 5%.
As of May 1, 2026, Nesroht Holding ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 25%.
As of April 30, 2026, Jesper Breum has left the board of directors of Tetra Pharm Technologies ApS.
As of April 8, 2026, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Tetra Pharm Technologies ApS.
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (March 30, 2026).
As of October 10, 2025, Breum Holding EST. 2016 ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 20%.
As of October 10, 2025, BrainFrame ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 20%.
Tetra Pharm Technologies ApS has published its annual report for 2024. Gross profit came to DKK 1,460,638, and the net result was DKK -55,213,708.
As of May 23, 2025, Søren Rose has left the board of directors of Tetra Pharm Technologies ApS.
As of April 1, 2025, Jesper Breum has joined the board of directors of Tetra Pharm Technologies ApS.
As of March 31, 2025, Jesper Breum has left the board of directors of Tetra Pharm Technologies ApS.
As of March 28, 2025, Nikolay Tretiyakov has left the board of directors of Tetra Pharm Technologies ApS.
Tetra Pharm Technologies ApS has published its annual report for 2023. Gross profit came to DKK 584,758, and the net result was DKK -32,946,869.
As of April 22, 2024, Lars Frøvang Thomsen has joined the board of directors of Tetra Pharm Technologies ApS.
As of April 22, 2024, Per Mogens Bugge has left the board of directors of Tetra Pharm Technologies ApS.
Tetra Pharm Technologies ApS has published its annual report for 2022. Gross profit came to DKK -510,296, and the net result was DKK -7,767,688.
As of August 1, 2022, OLE GS HOLDING ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 5%.
Tetra Pharm Technologies ApS has published its annual report for 2021. Gross profit came to DKK 3,208,286, and the net result was DKK 305,591.
As of January 12, 2022, is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 5%.
As of September 3, 2021, Per Mogens Bugge has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Jesper Breum has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Martin Stefan Rose has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Søren Rose has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Nikolay Tretiyakov has joined the board of directors of Tetra Pharm Technologies ApS.
Tetra Pharm Technologies ApS has published its interim report for the period August 26, 2019 to December 31, 2020.
As of December 1, 2020, Jesper Breum is registered as director of Tetra Pharm Technologies ApS.
As of August 26, 2019, Martin Stefan Rose is registered as director of Tetra Pharm Technologies ApS.
Tetra Pharm Technologies ApS was founded on August 26, 2019.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 46673034
CVR 46672909
CVR 41040351
CVR 26524938
CVR 42376558
